Update: Common anticholinergic meds seen to increase dementia risk

________________

Dear read­er,

It’s time for Sharp­Brains e‑newsletter dis­cussing the lat­est research and inno­va­tions to help pro­mote brain health, open­ing in this occa­sion with a large and wor­ry­ing study track­ing the long-term neur­al impact of com­mon­ly pre­scribed medications.

New brain research:

New brain technology:

New brain thinking:

 

Last but not least, here is a fun brain teas­er for the week­end.  What do you see?

 

Have a great month of July,

 

The Sharp­Brains Team

About SharpBrains

SHARPBRAINS is an independent think-tank and consulting firm providing services at the frontier of applied neuroscience, health, leadership and innovation.
SHARPBRAINS es un think-tank y consultoría independiente proporcionando servicios para la neurociencia aplicada, salud, liderazgo e innovación.

Top Articles on Brain Health and Neuroplasticity

Top 10 Brain Teasers and Illusions

Newsletter

Subscribe to our e-newsletter

* indicates required

Got the book?